文献速递妇科

纳入CA-125、HE4和体重指数的新算法在子宫内膜癌诊断中的应用

Novel algorithm including CA-125, HE4 and body mass index in the diagnosis of endometrial cancer.
PubMed 文献 · Gynecol Oncol · 2017-07-21

前瞻性病例对照研究纳入133例手术女性,比较血清CA-125和HE4水平在子宫内膜癌诊断与预后中的价值。CA-125、HE4联合体重指数的诊断模型区分子宫内膜癌与对照的AUC为0.804,灵敏度66.7%,特异度84.6%;HE4可预测深肌层浸润和淋巴血管间隙浸润。

要点

  • CA-125与HE4联合体重指数的诊断模型区分子宫内膜癌与对照的AUC为0.804。
  • HE4预测深肌层浸润AUC为0.78,预测淋巴血管间隙浸润AUC为0.81。
  • 在可避免淋巴结清扫的低危1-2级子宫内膜样癌中,HE4预测深肌层浸润AUC为0.84。

核心结论

  • 基于术前血清CA-125、HE4水平和体重指数的模型对区分子宫内膜癌患者与对照患者具有良好的诊断准确性。
  • 在子宫内膜癌患者中,血清HE4水平可预测深肌层浸润和淋巴血管间隙浸润。

研究设计与样本

  • 前瞻性病例对照研究,纳入在卢布尔雅那大学医学中心接受手术治疗的133例女性,其中子宫内膜癌患者64例,对照为子宫脱垂或子宫肌瘤患者69例。
  • 血清CA-125和HE4水平采用电化学发光法测定。

主要发现

  • 子宫内膜癌患者血清CA-125和HE4水平显著高于对照,P值分别为2.67×10-4和1.36×10-7。
  • 联合血清CA-125、HE4水平和体重指数的诊断模型区分子宫内膜癌与对照的AUC为0.804,灵敏度66.7%,特异度84.6%。
  • 血清HE4水平按深肌层浸润有无分层P=0.001,AUC为0.78;按淋巴血管间隙浸润有无分层P=0.003,AUC为0.81。
  • 在可避免淋巴结清扫的1级和2级子宫内膜样癌低危患者中,HE4按深肌层浸润分层P=3.39×10-4,AUC为0.84。
  • 淋巴血管间隙浸润患者的中位HE4水平较高,但差异未达统计学显著(P=0.06)。

局限性

  • 淋巴血管间隙浸润患者的中位HE4水平虽较高,但差异未达统计学显著(P=0.06)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To evaluate the diagnostic and prognostic potential of preoperative serum CA-125 and HE4 levels in patients with endometrial cancer. METHODS: Prospective case-control study of 133 women who underwent surgical treatment at the University Medical Centre Ljubljana (64 patients with endometrial cancer, 69 control patients with prolapsed uterus or myoma). Serum CA-125 and HE4 levels were determined using electrochemiluminescent assays. RESULTS: Serum CA-125 and HE4 levels were significantly higher in patients with endometrial cancer, compared to the controls (p=2.67×10-4, 1.36×10-7, respectively). A diagnostic model that combines serum CA-125 and HE4 levels and body mass index separated patients with endometrial cancer from controls, with AUC of 0.804, sensitivity of 66.7%, and specificity of 84.6%. Serum HE4 levels showed good prognostic potential and stratified the patients according to presence/absence of deep myometrial invasion (p=0.001) or lymphovascular invasion (p=0.003), with AUCs of 0.78 and 0.81, respectively. In low-risk patients with grade 1 and 2 endometrioid cancer for whom lymphadenectomy can be avoided, HE4 allowed stratification according to deep myometrial invasion (p=3.39×10-4), with AUC of 0.84. Although median HE4 levels were higher in patients with lymphovascular invasion, this difference did not reach significance (p=0.06). CONCLUSIONS: A model based on preoperative serum CA-125 and HE4 levels and body mass index has good diagnostic accuracy for separation of patients with endometrial cancer and control patients. In patients with endometrial cancer, serum HE4 levels allow prediction of deep myometrial and lymphovascular invasion.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Knific T, Osredkar J, Smrkolj Š, et al. Novel algorithm including CA-125, HE4 and body mass index in the diagnosis of endometrial cancer. Gynecol Oncol. 2017. PMID: 28735628. doi:10.1016/j.ygyno.2017.07.130

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。